Translate
Translate this website into the following languages:



Close Tab
Donations
UC San Diego Health
menu iconMenu
search iconSearch

Social Networking Evaluated to Improve Diabetes Management

 

July 11, 2012  |  

Researchers at the UC San Diego School of Medicine are evaluating a new social media tool called Wellaho to treat patients with type I and II diabetes. The clinical trial will study whether the use of social networking can improve patient-physician interactions and the patient’s overall health and wellbeing.

Jason Bronner
Jason Bronner, MD, UC San Diego Health System
“This trial will study how an online social network may better enable patient care,” said Jason Bronner, MD, associate clinical professor, UC San Diego School of Medicine and internist at UC San Diego Health System. “With a controlled group of the patient’s clinicians, friends, family and fellow patients, we will measure any changes in knowledge, attitudes and self care towards diabetes.”

Wellaho, developed by Sanitas Inc. in La Jolla, is an interactive online system designed to help patients manage their care outside the hospital. The system is HIPAA compliant, compatible with provider networks, and includes telemedicine capabilities.

“Social networking provides a common way for patients with chronic disease to learn about their condition while interacting with others in similar situations,” said Bronner. “As opposed to open networks, the use of this tool allows us to ensure that the medical information they receive and share is accurate, safe and absent of advertising.”

The online site provides self-monitoring tools as well as evidenced-based education customized for the patient’s specific condition. Subjects will be monitored for the number of times they access the site, length of use, and number of invited participants. The site will also track measures of weight, blood pressure, and glycostated hemoglobin.

“Long-term, we hope that patients will learn behaviors that impact blood sugar, control blood pressure, improve satisfaction and potentially decrease cost of care,” said Bronner.

According to the American Diabetes Association, diabetes now affects 25.8 million children and adults in the United States. An additional 79 million Americans are considered pre-diabetic.

To learn more about this clinical trial, please call 858-657-8000.

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu




Media Contact

Share This Article


Related News

2/22/2017
University of California San Diego School of Medicine researchers screened 10,000 colonies of bacteria found on the epidermis to determine how many had antimicrobial properties and at what rate these ...
2/17/2017
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San D ...
2/16/2017
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial scourge that is resistant to most common antibiotics and thus difficult to treat, particularly in children where it commonly causes co ...
2/15/2017
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteratio ...



Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: